207 related articles for article (PubMed ID: 30047046)
1. CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.
Li L; Fu LQ; Wang HJ; Wang YY
Pathol Oncol Res; 2020 Jan; 26(1):273-279. PubMed ID: 30047046
[TBL] [Abstract][Full Text] [Related]
2. Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.
Xu L; Peng S; Huang Q; Liu Y; Jiang H; Li X; Wang J
Oncol Rep; 2016 Oct; 36(4):1981-8. PubMed ID: 27573674
[TBL] [Abstract][Full Text] [Related]
3. [Association of adenylate cyclase-associated protein 2 expression with histopathology and long-term prognosis of gastric cancer].
Ge S; Wang S; Xiang W; Wang L; Zhu Y; Zhu X; Wang X; Zuo L; Jiang C; Li S; Liu M
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Sep; 39(9):1052-1058. PubMed ID: 31640951
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.
Adachi M; Masugi Y; Yamazaki K; Emoto K; Kobayashi Y; Tominaga E; Banno K; Aoki D; Sakamoto M
Jpn J Clin Oncol; 2020 Jun; 50(6):643-652. PubMed ID: 32211793
[TBL] [Abstract][Full Text] [Related]
5. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma.
Masugi Y; Tanese K; Emoto K; Yamazaki K; Effendi K; Funakoshi T; Mori M; Sakamoto M
Pathol Int; 2015 Dec; 65(12):627-34. PubMed ID: 26374196
[TBL] [Abstract][Full Text] [Related]
7. The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer.
Luo ZY; Wang YY; Zhao ZS; Li B; Chen JF
PLoS One; 2013; 8(7):e70311. PubMed ID: 23922976
[TBL] [Abstract][Full Text] [Related]
8. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients.
Wang YY; Li L; Zhao ZS; Wang YX; Ye ZY; Tao HQ
J Exp Clin Cancer Res; 2013 Sep; 32(1):66. PubMed ID: 24422715
[TBL] [Abstract][Full Text] [Related]
9. FAT2 is a novel independent prognostic factor for the poor prognosis of gastric carcinoma.
Li L; Fu LQ; Wang HJ; Yan ZL; Yu XC; Wang YY
Int J Clin Exp Pathol; 2017; 10(12):11603-11609. PubMed ID: 31966517
[TBL] [Abstract][Full Text] [Related]
10. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Nedd9 is a prognostic marker of human gastric cancer.
Zhang Q; Wang H; Ma Y; Zhang J; He X; Ma J; Zhao ZS
Med Oncol; 2014 Jul; 31(7):33. PubMed ID: 24906654
[TBL] [Abstract][Full Text] [Related]
12. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
17. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma.
Fu J; Li M; Wu DC; Liu LL; Chen SL; Yun JP
Transl Oncol; 2015 Oct; 8(5):400-406. PubMed ID: 26500030
[TBL] [Abstract][Full Text] [Related]
19. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
20. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
